Ultrasound
A |
Compared to
laparoscopy, trans-vaginal ultrasound (TVS) has no value in diagnosing
peritoneal endometriosis, but it is a useful tool both to make
and to exclude the diagnosis of an ovarian endometrioma ( Moore
et al., 2002). TVS may have a role in the diagnosis of disease
involving the bladder or rectum. |
Systematic
review of
diagnostic tests |
In a systematic review of the value of TVS as a diagnostic
tool in endometriosis, only seven out of the 49 papers identified fulfilled
the inclusion criteria (Moore
et al., 2002). The positive likelihood ratios ranged from 7.6 -
29.8, and the negative likelihood ratios ranged from 0.12 - 0.4. Confidence
intervals were wide. One paper addressed the use of conventional colour
Doppler with ultrasound: the positive likelihood ratio was 1.2, with
a negative likelihood ratio of 0.4 (Alcázar
et al., 1997). One paper assessed the use of colour Doppler energy
imaging, and showed a positive likelihood ratio of 33.5, and a negative
likelihood ratio of 0.11 (Guerriero
et al., 1998). Deep endometriosis in the bladder wall or rectum
may be visualised with TVS (Dessole
et al., 2003). Trans Rectal Sonography (TRS) may also be useful
for diagnosing rectovaginal endometriosis (sensitivity 80-100%, specificity
96-100%) (Fedele et al., 1998).
TRS performs better than magnetic resonance imaging (MRI) in the diagnosis
of rectal involvement for patients presenting with deeply infiltrating
endometriosis. For the diagnosis of rectal involvement, sensitivity,
specificity, PPV and NPV for TRS were 97.1%, 89.4%, 86.8% and 97.7%
and for MRI they were 76.5%, 97.9%, 96.3% and 85.2% (Chapron
et al., 2004).
Magnetic resonance imaging
At present, there is insufficient evidence to indicate
that magnetic resonance imaging (MRI) is a useful test to diagnose or
exclude endometriosis compared to laparoscopy.
Blood tests
A |
Serum CA-125
levels may be elevated in endometriosis. However, compared to
laparoscopy, measuring serum CA-125 levels has no value as a diagnostic
tool ( Mol et al., 1998).
|
Systematic
review of
diagnostic tests |
Investigations
to assess disease extent
GPP |
If there is
clinical evidence of deeply infiltrating endometriosis, ureteral,
bladder, and bowel involvement should be assessed. Consideration
should be given to performing MRI or ultrasound (trans-rectal
and/or trans-vaginal and/or renal), with or without IVP and barium
enema studies depending upon the individual circumstances, to
map the extent of disease present, which may be multi-focal. |
Assessment of ovarian cysts
GPP |
Local guidelines
for the management of suspected ovarian malignancy should be followed
in cases of ovarian endometrioma. Ultrasound scanning ±
serum CA-125 testing is usually used to try to identify rare instances
of ovarian cancer; however, CA-125 levels can be elevated in the
presence of endometriomas. |
Laparoscopy
GPP |
Good surgical practice is
to use an instrument such as a grasper, via a secondary port,
to mobilise the pelvic organs and to palpate lesions which can
help determine their nodularity. It is also important to document
in detail the type, location and extent of all lesions and adhesions
in the operative notes; ideal practice is to record the findings
on video or DVD. |
GPP |
There is insufficient evidence
to justify timing the laparoscopy at a specific time in the menstrual
cycle, but it should not be performed during or within three months
of hormonal treatment so as to avoid under-diagnosis. |
B |
At laparoscopy,
deeply infiltrating endometriosis may have the appearance of minimal
disease, resulting in an underestimation of disease severity ( Koninckx
et al., 1994). |
Evidence Level
3 |
Laparoscopy is the gold standard for diagnosing endometriosis,
although recognition of endometriosis will vary with the experience
of the surgeon, especially for subtle, bowel, bladder, ureteral and
diaphragmatic lesions. A meta-analysis of its value against a histological
diagnosis showed (assuming a 10% pre-test probability of endometriosis)
that a positive laparoscopy increases the likelihood of disease to 32%
(95% CI 21 to 46%) and a negative laparoscopy decreases the likelihood
to 0.7% (95% CI 0.1 to 5.0%) (Wykes
et al., 2004). However, diagnostic laparoscopy is associated with
an approximately 3% risk of minor complications (e.g. nausea, shoulder
tip pain) and a risk of major complications (e.g. bowel perforation,
vascular damage) of between 0.6 to 1.8 per 1000 (Chapron
et al., 1998; Harkki-Siren
et al., 1999).
At diagnostic laparoscopy, the pelvic and abdominal
cavity should be systematically searched for the presence of endometriosis.
This must include a complete and systematic inspection and palpation
with a blunt probe of the bowel, bladder, uterus, tubes, ovaries, cul-de-sac,
broad ligaments and the bottom of peritoneal pockets and hernial sacs.
The diagnosis of ovarian endometriosis is facilitated by careful inspection
of both ovaries in their entirety, which may be difficult when adhesions
are present in more advanced stages of the disease. Endometriosis can
be treated during laparoscopy, thus combining diagnosis and therapy.
Because chocolate like fluid may also be found in
other types of ovarian cysts, such as haemorrhagic corpus luteal or
neoplastic cysts, biopsy and preferably removal of the cyst for histological
confirmation is recommended if the cyst is > 3 cms diameter. Ovarian
endometriosis as a single finding occurs in < 1% of endometriosis
patients, the rest having mostly pelvic and/or intestinal endometriosis
as well (Redwine, 1999).
Classification systems
Many classification systems have been proposed, but
only one has been generally accepted. This is the revised American Fertility
Society (AFS) system (ASRM, 1997).
It is based on:
-
the appearance, size, and
depth of peritoneal and ovarian implants;
-
the presence, extent and
type of lesions: red (red, red-pink, and clear), white (white, yellow-brown,
and peritoneal defects) and black (black and blue);
-
the presence, extent, and
type of adnexal adhesions and the degree of cul-de-sac obliteration.
Colour photographs are provided by ASRM to assure
consistency in describing the appearance. This system reflects the extent
of endometriotic disease, but has considerable intra-observer and inter-observer
variability (Hornstein et
al., 1993; Lin et al., 1998).
Moreover, as the system was developed primarily for
the management of infertility, adnexal adhesions contribute disproportionately.
Similarly, they do not correlate with the signs and symptoms of the
disease, nor with the results of treatment. There are no data to demonstrate
that classifying the lesions contributes to any clinical outcome measures.
Concise